Hot Life Science Investor Mandate 2: Australian VC Looking Overseas for Life Science Opportunities

3 Jul

A venture capital firm headquartered in Melbourne, Australia is looking to make makes equity investments from $3M-5M. The firm anticipates about 6 new investments this year and looks to invest invests globally.

The firm will invest in companies across the life science space, including therapeutics, diagnostics and medical technology. The group does not invest in service providers. The firm considers all subsectors and indications, including orphan indications. The group will consider technology either in or prepared for human clinical trials and is open to all classes of devices. The firm seeks investments in novel technology and is not looking to gain share of an existing market.

The firm is open to co-investments and considers public or private companies. The group will only consider companies with granted patents or a clear patent strategy. Companies of interest must have a remote connection with Australia or the Pacific Region. This may include a facility or a partner located in the region.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: